Overview
Hiroyasu Kaneda practices practicing medicine in Osaka, Japan.
Kaneda is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Paronychia, and EGFR Positive Lung Cancer.
They are actively involved in clinical research, co-authoring 101 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroyasu Kaneda
Is Hiroyasu Kaneda a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroyasu Kaneda is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroyasu Kaneda participate in research or clinical trials?
Yes. Hiroyasu Kaneda has published 101 articles and abstracts on conditions like Lung Cancer. You can view a list of Hiroyasu Kaneda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerKaneda isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Kaneda isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerKaneda isAdvanced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaKaneda isAdvanced. Learn about Febrile Neutropenia.
- ParonychiaKaneda isAdvanced. Learn about Paronychia.
- Pleural EffusionKaneda isAdvanced. Learn about Pleural Effusion.
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Experienced
- Acute Interstitial PneumoniaKaneda isExperienced. Learn about Acute Interstitial Pneumonia.
- AgranulocytosisKaneda isExperienced. Learn about Agranulocytosis.
- Bone TumorKaneda isExperienced. Learn about Bone Tumor.
- Brain TumorKaneda isExperienced. Learn about Brain Tumor.
- Colorectal CancerKaneda isExperienced. Learn about Colorectal Cancer.
- Creutzfeldt-Jakob DiseaseKaneda isExperienced. Learn about Creutzfeldt-Jakob Disease.
- DysarthriaKaneda isExperienced. Learn about Dysarthria.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
- Familial Colorectal CancerKaneda isExperienced. Learn about Familial Colorectal Cancer.
- Gastrointestinal PerforationKaneda isExperienced. Learn about Gastrointestinal Perforation.
- HerniaKaneda isExperienced. Learn about Hernia.
- Interstitial Lung DiseaseKaneda isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaKaneda isExperienced. Learn about Lung Adenocarcinoma.
- MesotheliomaKaneda isExperienced. Learn about Mesothelioma.
- Ovarian CancerKaneda isExperienced. Learn about Ovarian Cancer.
- PIK3CA-Related Overgrowth Spectrum
- Stomach CancerKaneda isExperienced. Learn about Stomach Cancer.